Peter Warren’s (ASX: PWR) A$28m Wakeling deal clears ACCC after eight-dealership remedy

Peter Warren Automotive Holdings Limited (ASX: PWR) has cleared the biggest regulatory obstacle to its acquisition of Wakeling Automotive, with the Australian Competition and Consumer Commission approving the transaction subject to a divestment remedy covering eight dealership sites in Campbelltown and Smeaton Grange. Peter Warren said the approval remains subject to a mandatory 14-day review period under Australia’s new merger control regime and expects the acquisition to complete in the coming weeks.

The clearance revives a transaction originally announced in December 2025 at approximately A$28 million and involving 30 Wakeling Automotive dealerships representing 16 brands. At the time, Wakeling was generating around A$500 million of annual turnover, while Peter Warren said the acquisition was expected to be immediately earnings-per-share accretive after funding costs. The purchase consideration was expected to be funded through existing debt facilities.

What Peter Warren ultimately acquires, however, will now be economically different from the original unrestricted transaction. The ACCC concluded that without remedies, Peter Warren would have operated 25 of the 34 new-car dealerships in Sydney’s Macarthur region, a level of local concentration the regulator considered capable of substantially reducing competition in new-car sales, servicing and repairs. The remedy requires eight dealerships representing Kia, General Motors Specialty Vehicles, RAM, Isuzu UTE, GAC, Volkswagen and Suzuki to be divested.

Why did the ACCC force Peter Warren Automotive to sell eight dealerships before approving Wakeling?

The original Wakeling acquisition would have dramatically increased Peter Warren’s concentration in a market where consumers often purchase and service vehicles close to home. According to the ACCC, Peter Warren and Wakeling already overlap around Campbelltown, Narellan and Smeaton Grange, making local dealership concentration more important than simply looking at Peter Warren’s share of automotive retailing across Australia.

The regulator calculated that the combined company would have controlled 25 of 34 new-car dealerships in the Macarthur region without a remedy. That equates to approximately 74% of the dealership count, although dealership numbers alone do not measure vehicle sales, revenue or market share because different franchises can sell materially different volumes. The figure nevertheless explains why the transaction became one of the more closely watched tests of Australia’s new mandatory merger notification system.

Peter Warren initially notified the acquisition in March 2026. The ACCC moved the transaction into an in-depth Phase 2 review in June after concluding that the deal could substantially lessen competition, but Peter Warren subsequently withdrew that process and returned in July with a revised Phase 1 notification containing a proposed divestment remedy. The September 4 clearance therefore represents the outcome of several months of negotiations rather than a routine regulatory sign-off.

The remedy also offers a useful indication of how the new Australian regime may operate in highly concentrated regional markets. Rather than blocking the acquisition entirely, the ACCC has allowed Peter Warren to pursue its broader consolidation strategy while requiring enough local assets to pass to alternative operators to preserve competitive tension.

How significant was Wakeling Automotive compared with Peter Warren’s existing business?

The original Wakeling transaction was sizeable in operational terms even though the headline purchase consideration was modest relative to the revenue being acquired. Wakeling was producing approximately A$500 million in annual turnover when the acquisition was announced, while Peter Warren reported FY26 revenue of A$2.489 billion. On that comparison, Wakeling’s pre-divestment annual turnover equalled roughly 20% of Peter Warren’s FY26 revenue.

The approximate A$28 million announced consideration equalled just 5.6% of Wakeling’s reported annual turnover. That does not mean Peter Warren was buying the company at a 0.056-times enterprise-value-to-sales multiple because dealership transactions include working capital, inventory, floorplan financing, property arrangements and other balance-sheet considerations that cannot be captured by comparing goodwill or cash consideration with sales alone. Peter Warren originally described the amount as approximately A$21.7 million of goodwill plus net assets at completion.

The acquisition also needs to be reconsidered following the divestment requirement. Peter Warren has not disclosed a revised purchase consideration, updated Wakeling revenue contribution or revised earnings accretion estimate reflecting the assets that must be sold. Investors therefore should not automatically apply the December 2025 A$500 million turnover figure to the business Peter Warren will ultimately retain.

That is arguably the most important unanswered financial question following the regulatory clearance. The transaction has moved much closer to completion, but the regulatory remedy means the acquisition economics now need to be refreshed before investors can precisely assess the revenue, profit and return on capital Peter Warren will obtain.

Why does the Wakeling deal matter more after Peter Warren’s FY26 profit fell 35%?

Peter Warren entered FY27 from a difficult earnings year. FY26 revenue remained broadly stable at A$2.489 billion, but underlying profit before tax fell 35% to A$14.5 million from A$22.3 million. Underlying EBITDA declined to A$97.6 million from A$110.1 million, while statutory profit before tax fell to A$11.5 million after approximately A$3 million of acquisition-related and restructuring costs.

The earnings pressure did not come from a collapse in overall sales. Gross profit increased to A$406 million and gross margin improved to 16.3%, but operating expenses increased A$18.7 million to A$308.4 million as Peter Warren absorbed costs associated with new brands, new dealerships and inflation. Management also reported pressure on new-vehicle margins as established brands competed against rapidly expanding market entrants.

At the same time, higher-margin areas performed more strongly. Used vehicle sales reached a record 10,578 units and service and parts revenue increased to A$442 million. Those businesses matter because dealership acquisitions potentially create recurring service, parts, finance and used-car opportunities long after the initial new vehicle is sold.

Wakeling therefore arrives at a strategically sensitive point. Peter Warren needs more than additional revenue from the transaction. It needs acquired dealerships to contribute enough gross profit and operating leverage to help reverse the FY26 decline in underlying earnings.

The original claim that Wakeling would be immediately EPS accretive remains encouraging, but it predates the final divestment remedy. The cleaner test will come when Peter Warren discloses the revised expected earnings contribution after determining exactly which businesses it retains and what consideration is ultimately paid.

Does the ACCC remedy undermine Peter Warren’s automotive consolidation strategy?

Not necessarily. Peter Warren already operates more than 80 franchise operations and represents more than 30 automotive manufacturers across volume, prestige and luxury segments on Australia’s eastern seaboard. Wakeling still offers the company additional exposure across Greater Sydney, Wollongong and the Southern Highlands even after the required asset sales.

The larger strategic question concerns how much value comes from local density. Automotive dealership groups can potentially improve profitability through shared management, inventory management, digital marketing, finance, insurance, parts distribution and back-office operations. A denser geographic network can magnify those advantages, which is precisely why regulators become concerned when consolidation goes too far.

The eight-site remedy effectively places a regulatory ceiling on some of those potential density benefits. Peter Warren should still become considerably larger through Wakeling, but it will not enjoy the concentration in Macarthur that the original 30-dealership acquisition would have created.

There may also be value in the divestment process itself if Peter Warren can secure acceptable prices for the businesses that must be sold. No purchaser or divestment value has yet been disclosed, however, so investors cannot currently quantify how much capital could be recovered through the remedy.

Why did Peter Warren Automotive shares rise after the ACCC decision?

Peter Warren shares closed September 4 at A$0.80, up 3.23% from A$0.775 in the previous session after trading as high as A$0.845. The positive reaction indicates that investors viewed regulatory clearance as reducing an important source of uncertainty despite the eight-site divestment condition.

The broader share-price picture remains far less comfortable. Peter Warren’s 52-week range extends from approximately A$0.715 to A$2.05, leaving the September 4 close around 61% below the upper end of that range. The shares were also approximately 15% below their August 4 level and had fallen sharply following the FY26 results announcement.

That backdrop explains why Wakeling could become an important FY27 sentiment driver. Investors have already absorbed a 35% decline in underlying PBT and substantial share-price weakness. A successfully integrated acquisition capable of increasing higher-margin service, parts and used-car earnings could support a recovery narrative, while delayed integration or weak acquisition economics would reinforce concerns about cost pressure and returns from expansion.

The ACCC decision solves the binary question of whether the transaction can proceed. It does not yet answer the harder questions around the profitability of the retained Wakeling assets, disposal proceeds from the eight dealerships or the speed at which Peter Warren can convert greater scale into higher earnings.

For that reason, the September 4 clearance should be viewed as the beginning of the financial assessment rather than the end. Peter Warren has won permission to complete a strategically important acquisition, but shareholders now need updated economics showing what the regulatory compromise ultimately buys them.